Complete Filing Data
Context Therapeutics Inc. reported Stockholders Equity of $60.47 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Context Therapeutics Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$36.1M | -$26.7M | -$24.0M | -$14.8M | -$10.5M | $6.6M |
| Research And Development Expense Excluding Acquired In Process Cost | $31.9M | $22.7M | $17.8M | $7.1M | $3.8M | $1.6M |
| Operating Income Loss | -$39.7M | -$29.9M | -$25.1M | -$15.4M | -$10.5M | -$2.6M |
| General And Administrative Expense | $7.8M | $7.2M | $7.3M | $7.8M | $3.6M | $930.7K |
| Nonoperating Income Expense | -$55.6K | -$2.0K | $123.9K | $0.00 | ||
| Interest Income Expense Net | $1.2M | $547.3K | -$64.2K | |||
| Research And Development In Process | $500.0K | $3.1M | $0.00 | |||
| Research And Development Expense Acquired In Process | $2.0M | $14.8M | $0.00 | $500.0K | ||
| Other Nonoperating Income Expense | $200.5K | -$1.4K | -$55.6K | |||
| Interest Expense | $64.2K | $661.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$9.7M | -$8.8M | -$4.6M | -$17.5M | -$2.3M | -$3.7M | -$5.9M | -$5.0M | -$6.3M | -$3.9M | -$4.0M | -$3.4M | -$1.4M | -$5.0M | -$892.0K | -$876.2K | $7.5M | $826.5K |
| Research And Development Expense Excluding Acquired In Process Cost | $8.7M | $7.8M | $3.5M | $16.8M | $1.4M | $2.0M | $4.5M | $3.5M | $4.5M | $2.1M | $1.5M | $1.4M | $739.6K | $1.3M | $438.7K | $468.7K | ||
| Operating Income Loss | -$10.6M | -$9.8M | -$5.5M | -$18.7M | -$3.1M | -$3.8M | -$6.2M | -$5.3M | -$6.7M | -$4.0M | -$4.0M | -$3.4M | -$1.6M | -$5.0M | -$840.3K | -$651.1K | ||
| General And Administrative Expense | $1.9M | $1.9M | $2.1M | $1.9M | $1.7M | $1.9M | $1.7M | $1.8M | $2.1M | $2.0M | $2.0M | $2.1M | $828.5K | $604.6K | $401.6K | $182.4K | ||
| Nonoperating Income Expense | -$2.2K | -$6.1K | $3.4K | $15.4K | -$12.2K | $2.7K | $1.5K | $4.00 | -$1.2K | $126.5K | -$4.3K | $1.9K | $0.00 | |||||
| Interest Income Expense Net | $1.2M | $840.2K | $152.4K | $290.4K | $293.3K | $355.5K | $192.2K | $21.3K | $5.9K | -$1.3K | -$309.00 | -$63.0K | ||||||
| Research And Development In Process | $0.00 | $500.0K | $0.00 | $3.1M | $0.00 | |||||||||||||
| Research And Development Expense Acquired In Process | $0.00 | $0.00 | $0.00 | $500.0K | ||||||||||||||
| Other Nonoperating Income Expense | $83.5K | $27.1K | -$6.6K | -$2.2K | -$6.1K | $3.4K | ||||||||||||
| Interest Expense | $1.3K | $95.2K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $60.5M | $95.3M | $11.9M | $34.8M | $48.3M | -$16.9M | -$24.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $66.0M | $94.4M | $14.4M | $35.5M | $49.7M | $341.0K | $226.6K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$28.4M | $80.0M | -$21.0M | -$14.2M | $49.3M | $114.4K | |
| Retained Earnings Accumulated Deficit | -$130.9M | -$94.8M | -$68.1M | -$44.1M | -$29.3M | -$18.8M | |
| Prepaid Expense And Other Assets Current | $2.4M | $3.5M | $1.6M | $2.4M | $1.6M | $8.7K | |
| Liabilities Current | $8.0M | $2.7M | $4.2M | $3.2M | $3.0M | $9.5M | |
| Liabilities And Stockholders Equity | $68.5M | $98.1M | $16.1M | $38.0M | $51.3M | $467.3K | |
| Liabilities | $8.0M | $2.9M | $4.2M | $3.2M | $3.0M | $9.6M | |
| Common Stock Value | $91.9K | $89.7K | $16.0K | $16.0K | $16.0K | $332.00 | |
| Cash And Cash Equivalents At Carrying Value | $66.0M | $94.4M | $14.4M | $35.5M | $49.6M | $290.7K | |
| Assets Current | $68.4M | $97.9M | $16.0M | $37.9M | $51.3M | $299.3K | |
| Assets | $68.5M | $98.1M | $16.1M | $38.0M | $51.3M | $467.3K | |
| Accrued Liabilities Current | $5.4M | $1.2M | $1.8M | $2.2M | $1.2M | $956.0K | |
| Accounts Payable Current | $2.5M | $1.5M | $2.4M | $936.3K | $1.8M | $2.7M | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Property Plant And Equipment Net | $29.7K | $12.0K | $15.5K | $27.6K | $0.00 | ||
| Operating Lease Right Of Use Asset | $110.4K | $218.8K | $0.00 | $52.0K | $0.00 | ||
| Operating Lease Liability Current | $112.1K | $107.3K | $0.00 | $55.1K | $0.00 | ||
| Fair Value Adjustment On Convertible Debt | $0.00 | $9.3K | $9.9M | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $260.6K | $0.00 | $130.5K | $0.00 | ||
| Operating Lease Right Of Use Asset Amortization Expense | |||||||
| Deferred Offering Cost Incurred But Not Yet Paid | $0.00 | $102.1K | $117.6K | ||||
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock | $53.3K | -$97.0K | |||||
| Other Assets Noncurrent | $0.00 | $32.8K | $0.00 | ||||
| Operating Lease Liability Noncurrent | $0.00 | $112.1K | $0.00 | ||||
| Temporary Equity Offering Costs | $310.0K | ||||||
| Restricted Cash Noncurrent | $0.00 | $50.4K | $50.4K | ||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $125.6K | $0.00 | ||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $7.8M | |||||
| Notes Payable Current | $0.00 | $55.0K | |||||
| Long Term Notes Payable | $0.00 | $69.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $73.2M | $82.5M | $91.0M | $83.9M | $101.1M | $8.4M | $18.4M | $24.0M | $28.7M | $38.1M | $41.6M | $45.4M | -$23.2M | -$22.3M | -$17.5M | -$16.2M | -$15.4M | -$23.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $76.9M | $83.5M | $89.4M | $84.8M | $101.5M | $10.1M | $21.7M | $25.1M | $29.8M | $39.4M | $42.9M | $45.7M | $419.2K | $1.3M | $1.7M | $167.1K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$5.1M | -$4.4M | -$5.7M | -$4.0M | $1.3M | ||||||||||||||
| Retained Earnings Accumulated Deficit | -$117.9M | -$108.2M | -$99.4M | -$91.4M | -$74.0M | -$71.7M | -$61.3M | -$55.4M | -$50.4M | -$40.5M | -$36.7M | -$32.7M | -$26.2M | ||||||
| Prepaid Expense And Other Assets Current | $2.1M | $3.4M | $3.4M | $1.3M | $1.2M | $949.5K | $1.3M | $2.6M | $2.1M | $2.5M | $1.6M | $1.1M | $18.4K | ||||||
| Liabilities Current | $6.0M | $4.6M | $1.9M | $2.3M | $1.6M | $2.6M | $4.6M | $3.8M | $3.2M | $4.0M | $3.0M | $1.6M | $4.4M | ||||||
| Liabilities And Stockholders Equity | $79.2M | $87.2M | $93.0M | $86.3M | $102.7M | $11.1M | $23.0M | $27.8M | $32.0M | $42.1M | $44.7M | $47.0M | $2.3M | ||||||
| Liabilities | $6.1M | $4.6M | $2.0M | $2.5M | $1.6M | $2.6M | $4.6M | $3.8M | $3.2M | $4.0M | $3.0M | $1.6M | $4.4M | ||||||
| Common Stock Value | $91.9K | $89.7K | $89.7K | $75.0K | $75.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $348.00 | ||||||
| Cash And Cash Equivalents At Carrying Value | $76.9M | $83.5M | $89.4M | $84.8M | $101.5M | $10.1M | $21.7M | $25.1M | $29.8M | $39.4M | $42.9M | $45.7M | $419.2K | ||||||
| Assets Current | $79.1M | $86.9M | $92.7M | $86.1M | $102.7M | $11.0M | $23.0M | $27.7M | $31.9M | $41.9M | $44.5M | $46.9M | $437.5K | ||||||
| Assets | $79.2M | $87.2M | $93.0M | $86.3M | $102.7M | $11.1M | $23.0M | $27.8M | $32.0M | $42.1M | $44.7M | $47.0M | $2.3M | ||||||
| Accrued Liabilities Current | $3.2M | $2.0M | $787.8K | $1.2M | $992.8K | $563.1K | $2.8M | $2.6M | $2.0M | $2.4M | $2.0M | $1.1M | $1.3M | ||||||
| Accounts Payable Current | $2.7M | $2.4M | $1.0M | $1.0M | $611.5K | $2.0M | $1.8M | $1.2M | $1.2M | $1.5M | $945.5K | $454.8K | $3.1M | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Property Plant And Equipment Net | $33.7K | $37.8K | $41.9K | $14.9K | $10.4K | $13.0K | $18.1K | $21.2K | $24.4K | $30.8K | $34.0K | $35.0K | |||||||
| Operating Lease Right Of Use Asset | $138.6K | $166.1K | $192.8K | $244.1K | $0.00 | $7.5K | $29.9K | $73.8K | $95.3K | $116.5K | |||||||||
| Operating Lease Liability Current | $119.0K | $115.0K | $111.1K | $104.2K | $0.00 | $8.0K | $31.7K | $78.2K | $93.1K | $91.9K | |||||||||
| Fair Value Adjustment On Convertible Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $9.3K | -$130.0K | ||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $130.5K | $0.00 | ||||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $26.0K | $0.00 | $22.1K | $14.0K | $0.00 | ||||||||||||||
| Deferred Offering Cost Incurred But Not Yet Paid | $0.00 | $463.1K | |||||||||||||||||
| Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock | $53.3K | $1.0K | -$82.0K | -$13.0K | |||||||||||||||
| Other Assets Noncurrent | $0.00 | $24.0K | $26.2K | $39.3K | $67.8K | $24.0K | |||||||||||||
| Operating Lease Liability Noncurrent | $21.2K | $52.3K | $82.6K | $140.2K | $8.0K | $31.7K | $0.00 | ||||||||||||
| Temporary Equity Offering Costs | $96.9K | $213.1K | |||||||||||||||||
| Restricted Cash Noncurrent | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Gains Losses On Extinguishment Of Debt | |||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $21.1M | ||||||||||||||||||
| Notes Payable Current | $0.00 | ||||||||||||||||||
| Long Term Notes Payable | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $1.3M | $841.9K | $1.1M | $976.4K | $511.1K | $219.2K |
| Net Cash Provided By Used In Operating Activities | -$26.4M | -$14.6M | -$21.0M | -$13.5M | -$8.8M | -$1.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.1M | $1.9M | -$758.8K | $736.0K | $1.6M | -$4.3K |
| Increase Decrease In Accrued Liabilities | $4.2M | -$619.8K | -$407.5K | $1.4M | $252.7K | $757.7K |
| Increase Decrease In Accounts Payable | $1.1M | -$946.1K | $1.4M | -$787.9K | -$866.0K | $556.3K |
| Net Cash Provided By Used In Financing Activities | -$15.3K | $109.3M | $0.00 | -$102.1K | $58.4M | $1.1M |
| Net Cash Provided By Used In Investing Activities | -$2.0M | -$14.8M | $0.00 | -$536.8K | -$250.0K | $0.00 |
| Increase Decrease In Operating Lease Liability | -$107.3K | -$41.3K | -$55.1K | -$75.4K | $0.00 | |
| Depreciation Depletion And Amortization | $16.3K | $10.9K | $12.0K | $9.3K | $0.00 | |
| Payments To Acquire Property Plant And Equipment | $33.9K | $7.3K | $0.00 | $36.8K | $0.00 | |
| Payments To Acquire In Process Research And Development | $2.0M | $14.8M | $0.00 | $500.0K | $250.0K | $0.00 |
| Stock Issued During Period Value Share Based Compensation Gross | $511.1K | $219.2K | ||||
| Payments Of Stock Issuance Costs | $15.3K | $0.00 | $0.00 | $102.1K | $100.0K | |
| Increase Decrease In Other Noncurrent Assets | ||||||
| Increase Decrease In Fair Value Of Redeemable Common Stock To Redemption Value | $0.00 | $53.3K | $97.0K | |||
| Proceeds From Issuance Of Private Placement | $0.00 | $94.8M | $0.00 | $0.00 | $29.0M | $0.00 |
| Proceeds From Issuance Of Other Long Term Debt | $0.00 | $124.1K | ||||
| Proceeds From Issuance Initial Public Offering | $0.00 | $24.4M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $293.7K | $240.0K | $282.8K | $215.0K | $25.5K | |||||
| Net Cash Provided By Used In Operating Activities | -$5.0M | -$4.4M | -$5.7M | -$3.8M | -$1.7M | |||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$87.6K | -$647.9K | -$239.5K | -$491.1K | $1.7K | |||||
| Increase Decrease In Accrued Liabilities | -$401.2K | -$1.2M | -$224.7K | $198.3K | $398.5K | |||||
| Increase Decrease In Accounts Payable | -$435.6K | -$337.7K | $273.9K | -$1.3M | -$1.3M | |||||
| Net Cash Provided By Used In Financing Activities | -$15.3K | $0.00 | $0.00 | -$102.1K | $3.0M | |||||
| Net Cash Provided By Used In Investing Activities | -$33.9K | $0.00 | $0.00 | -$35.0K | $0.00 | |||||
| Increase Decrease In Operating Lease Liability | -$25.7K | $0.00 | -$23.4K | -$6.9K | $0.00 | |||||
| Depreciation Depletion And Amortization | $4.1K | $2.6K | $3.2K | $0.00 | ||||||
| Payments To Acquire Property Plant And Equipment | $33.9K | $0.00 | $0.00 | $35.0K | $0.00 | |||||
| Payments To Acquire In Process Research And Development | ||||||||||
| Stock Issued During Period Value Share Based Compensation Gross | $161.8K | $119.4K | $25.5K | $30.8K | $30.6K | $127.0K | ||||
| Payments Of Stock Issuance Costs | $15.3K | $0.00 | $102.1K | $0.00 | ||||||
| Increase Decrease In Other Noncurrent Assets | $0.00 | -$6.6K | $24.0K | $0.00 | ||||||
| Increase Decrease In Fair Value Of Redeemable Common Stock To Redemption Value | ||||||||||
| Proceeds From Issuance Of Private Placement | ||||||||||
| Proceeds From Issuance Of Other Long Term Debt | ||||||||||
| Proceeds From Issuance Initial Public Offering |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 95.2M | 58.4M | 16.0M | 16.0M | 2.8M | 348.4K |
| Weighted Average Number Of Diluted Shares Outstanding | 95.2M | 58.4M | 16.0M | 16.0M | 2.8M | 2.1M |
| Earnings Per Share Diluted | $-0.38 | $-0.46 | $-1.50 | $-0.93 | $-3.69 | $-3.96 |
| Earnings Per Share Basic | $-0.38 | $-0.46 | $-1.50 | $-0.93 | $-3.69 | $3.07 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 91.9M | 89.7M | 16.0M | 16.0M | 16.0M | 331.8K |
| Common Stock Shares Issued | 91.9M | 89.7M | 16.0M | 16.0M | 16.0M | 331.8K |
| Common Stock Shares Authorized | 200.0M | 200.0M | 100.0M | 100.0M | 100.0M | 100.0M |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 95.2M | 95.2M | 95.2M | 80.5M | 55.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 361.1K | 354.8K | 349.2K | 348.4K | |
| Weighted Average Number Of Diluted Shares Outstanding | 95.2M | 95.2M | 95.2M | 80.5M | 55.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 361.1K | 354.8K | 349.2K | 348.4K | |
| Earnings Per Share Diluted | $-0.10 | $-0.09 | $-0.05 | $-0.22 | $-0.04 | $-0.23 | $-0.37 | $-0.31 | $-0.40 | $-0.24 | $-0.25 | $-0.22 | $-4.00 | $-14.18 | $-2.55 | $-2.52 | |
| Earnings Per Share Basic | $-0.10 | $-0.09 | $-0.05 | $-0.22 | $-0.04 | $-0.23 | $-0.37 | $-0.31 | $-0.40 | $-0.24 | $-0.25 | $-0.22 | $-4.00 | $-14.18 | $-2.55 | $-2.52 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 91.9M | 89.7M | 89.7M | 75.0M | 75.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 348.5K | ||||
| Common Stock Shares Issued | 91.9M | 89.7M | 89.7M | 75.0M | 75.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 16.0M | 348.5K | ||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.3M | $841.9K | $1.1M | $976.4K | ||
| Additional Paid In Capital | $191.3M | $190.0M | $79.9M | $78.8M | $77.5M | $1.9M |
| Paid In Kind Interest | $0.00 | $46.3K | $661.2K | |||
| Stock Issued1 | $0.00 | $2.8M | $0.00 | |||
| Investment Income Interest | $3.4M | $3.2M | $1.2M | |||
| Fair Value Adjustment Of Warrants | $0.00 | $371.9K | $0.00 | |||
| Warrants Issued | $0.00 | $309.4K | $79.0K | |||
| Adjustments To Additional Paid In Capital Warrant Issued | $345.5K | |||||
| Issuance Of Stock And Warrants For Services Or Claims | $2.2K | $0.00 | $0.00 | $345.5K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $323.1K | $389.1K | $293.7K | $213.0K | $157.0K | $240.0K | $254.9K | $283.1K | $282.8K | $276.5K | $241.3K | $215.0K | ||
| Additional Paid In Capital | $191.0M | $190.6M | $190.2M | $175.2M | $175.0M | $80.1M | $79.7M | $79.4M | $79.1M | $78.6M | $78.3M | $78.1M | $2.9M | |
| Paid In Kind Interest | $0.00 | $63.0K | ||||||||||||
| Stock Issued1 | ||||||||||||||
| Investment Income Interest | $833.8K | $903.8K | $958.5K | $1.2M | $840.2K | $152.4K | ||||||||
| Fair Value Adjustment Of Warrants | ||||||||||||||
| Warrants Issued | ||||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $345.5K | $100.0K | ||||||||||||
| Issuance Of Stock And Warrants For Services Or Claims |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.